Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Howard Short

Ophthalmology Washington, MO Medical Doctor

NPI 1013987551 CMS profile 137150

1351 Jefferson St, Ste 110, Washington, MO 63090

Open in the dashboard

General payments

$1,841

48 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Howard Short of Washington, MO is reported in the CMS Open Payments database as having received $1,841 across 48 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 57th percentile of Ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $17 1
2020 General $432 15
2019 General $1,393 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Howard Short
  • Ophthalmology median
  • Middle half of Ophthalmology
  • National median

In program year 2025, general payments to Howard Short were reported at $0. Among 13,034 Ophthalmology profiles paid that year, the median was $384 and the middle half received between $136 and $917.

Show as a table
Year Howard Short Ophthalmology median Middle half National median
2019 $1,393 $258 $104–$655 $163
2020 $432 $126 $45–$321 $114
2021 $17 $205 $76–$534 $132
2022 $0 $266 $100–$678 $149
2023 $0 $308 $117–$745 $160
2024 $0 $340 $127–$846 $164
2025 $0 $384 $136–$917 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. TissueTech, Inc. $687 16 payments
  2. Johnson & Johnson Surgical Vision, Inc. $243 5 payments
  3. Kala Pharmaceuticals, Inc. $196 6 payments
  4. Allergan Inc. $186 6 payments
  5. Glaukos Corporation $158 2 payments
  6. Alcon Vision LLC $133 5 payments
  7. Aerie Pharmaceuticals, Inc. $116 1 payment
  8. Sun Pharmaceutical Industries Inc. $38 2 payments
  9. Bausch & Lomb, a division of Bausch Health US, LLC $35 2 payments
  10. EyePoint Pharmaceuticals US, Inc. $31 2 payments
  11. Other $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Food and Beverage $1,841 48 payments
Products named General payments · program years 2019–2021
  1. Prokera $671 15 payments
  2. AmnioGraft $671 15 payments
  3. AmnioGuard $671 15 payments
  4. INVELTYS $196 6 payments
  5. iStent inject Trabecular Micro-Bypass Stent System $158 2 payments
  6. Tecnis Symfony IOL $142 2 payments
  7. Rhopressa $116 1 payment
  8. Rocklatan $116 1 payment
  9. Tecnis 1-piece IOL $74 1 payment
  10. Tecnis 3-piece IOL $74 1 payment
  11. Other $662 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

48 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Ophthalmology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record